IGHE and asthma: No statistically significant correlations were detected between either serum IgE levels or baseline blood eosinophils, and dupilumab-induced changes in the following parameters: reduction in asthma exacerbations (Figures 3A, 4A), decrease in daily prednisone dose (Figures 3B, 4B), increases in ACT score (Figures 3C, 4C), FEV1 (Figures 3D, 4D), FVC (Figures 3E, 4E), and FEF25-75 (Figures 3F, 4F).